Genetic Variants in COX-2, Non-Steroidal Anti-Inflammatory Drugs, and Breast Cancer Risk: The Western New York Exposures and Breast Cancer (WEB) Study

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-1082-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Breast Cancer Risk: Differences by Molecular Subtype

Cancer Causes and Control
Cancer ResearchOncology
2011English

Non-Steroidal Anti-Inflammatory Drug Use, Hormone Receptor Status, and Breast Cancer-Specific Mortality in the Carolina Breast Cancer Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2014English

Non-Steroidal Anti-Inflammatory Drugs and Small Cell Lung Cancer Risk in the VITAL Study

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2012English

Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Genetic Variants in the MRPS30 Region and Postmenopausal Breast Cancer Risk

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2012English

Inflammatory Markers and Breast Cancer Risk

2011English

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

British Medical Journal
Medicine
2013English

Non-Steroidal Anti-Inflammatory Drugs and Peptic Ulcers.

BMJ
1990English

Inflammatory Markers and Breast Cancer Risk

2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy